Mirae Asset Global Investments’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $8.34K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $4.38K | Buy |
|
|||||
|
2024
Q2 | $5.82K | Sell |
|
|||||
|
2024
Q1 | $277K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $270K | Buy |
|
|||||
|
2023
Q2 | $188K | Sell |
|
|||||
|
2023
Q1 | $403K | Buy |
|
|||||
|
2022
Q4 | $347K | Buy |
|
|||||
|
2022
Q3 | $421K | Buy |
|
|||||
|
2022
Q2 | $146K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.42M | Sell |
|
|||||
|
2021
Q1 | $1.7M | Sell |
|
|||||
|
2020
Q4 | $2.12M | Sell |
|
|||||
|
2020
Q3 | $2.28M | Buy |
|
|||||
|
2020
Q2 | $1.45M | Sell |
|
|||||
|
2020
Q1 | $1.93M | Sell |
|
|||||
|
2019
Q4 | $3.04M | Sell |
|
|||||
|
2019
Q3 | $4.54M | Sell |
|
|||||
|
2019
Q2 | $6.67M | Buy |
|
|||||
|
2019
Q1 | $4.11M | Buy |
|
|||||
|
2018
Q4 | $2.63M | Sell |
|
|||||
|
2018
Q3 | $6.2M | Buy |
|
|||||
|
2018
Q2 | $4.61M | Buy |
|